Occurrence and fate of pharmaceutically active compounds in the largest municipal wastewater treatment plant in Southwest China: Mass balance analysis and consumption back-calculated model

Chemosphere

Volumn 99, Issue , 2014, Pages 160-170

  Yan, Qing ^a,b   Gao, Xu ^c   Huang, Lei ^a   Gan, Xiu Mei ^a   Zhang, Yi Xin ^a   Chen, You Peng ^a,d   Peng, Xu Ya ^a   Guo, Jin Song ^a,d  

^a CHONGQING UNIVERSITY   (China)

^b CHONGQING NORMAL UNIVERSITY   (China)

^c Chongqing Water Group Co Ltd   (China)

^d University of Chinese Academy of Sciences   (China)

Author keywords

China; Mass balance analysis; Pharmaceutical consumption back calculated model; Pharmaceutically active compound; Sludge; Wastewater

Indexed keywords

ACTIVATED SLUDGE PROCESS; ANTIBIOTICS; BIOASSAY; BIODEGRADATION; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SEWAGE PUMPING PLANTS; WASTEWATER; WATER TREATMENT PLANTS;

CHINA; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; INFLUENT CONCENTRATIONS; MASS BALANCE ANALYSIS; MUNICIPAL WASTEWATER TREATMENT PLANTS; PHARMACEUTICALLY ACTIVE COMPOUNDS; SLUDGE; WASTEWATER TREATMENT PLANTS;

WASTEWATER TREATMENT;

AMLODIPINE; ATORVASTATIN; AZITHROMYCIN; BEZAFIBRATE; CARBAMAZEPINE; CLOFIBRIC ACID; DICLOFENAC; ERYTHROMYCIN; GEMFIBROZIL; IBUPROFEN; METOPROLOL; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PARACETAMOL; QUINOLONE DERIVATIVE; ROXITHROMYCIN; SIMVASTATIN; SULFADIAZINE; SULFADIMIDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTICS; CHEMICAL MASS BALANCE; CONCENTRATION (COMPOSITION); ENVIRONMENTAL FATE; NUMERICAL MODEL; POLLUTANT REMOVAL; REACTION KINETICS; SLUDGE; WASTEWATER;

ARTICLE; BIODEGRADATION; BIOTRANSFORMATION; CHINA; CONSUMPTION BACK CALCULATED MODEL; DEVELOPED COUNTRY; ENVIRONMENTAL IMPACT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS BALANCE ANALYSIS; MATHEMATICAL MODEL; SLUDGE; TANDEM MASS SPECTROMETRY; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER SAMPLING;

CHINA; CHONGQING;

CHINA; MASS BALANCE ANALYSIS; PHARMACEUTICAL CONSUMPTION BACK-CALCULATED MODEL; PHARMACEUTICALLY ACTIVE COMPOUND; SLUDGE; WASTEWATER;

BIODEGRADATION, ENVIRONMENTAL; CHINA; ENVIRONMENTAL MONITORING; HUMANS; MODELS, CHEMICAL; OFLOXACIN; PHARMACEUTICAL PREPARATIONS; SEWAGE; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84893635103     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.10.062     Document Type: Article

References (62)

1. Adams M., Tavakoli H. Gatifloxacin-induced hallucinations in a 19-year-old man. Psychosomatics 2006, 47:360.
2. Alder A.C., Bruchet A., Carballa M., Clara M., Joss A., Loffler D., McArdell C.S., Miksch K., Omil F., Tuhkanen T., Ternes T.A. Consumption and occurrence. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management 2006, 15-54. IWA Publishing, London, UK. T.A. Ternes, A. Joss (Eds.).
3. Aydin E., Talinli I. Analysis, occurrence and fate of commonly used pharmaceuticals and hormones in the Buyukcekmece Watershed, Turkey. Chemosphere 2013, 90:2004-2012.
4. Behera S.K., Kim H.W., Oh J.E., Park H.S. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. The Science of the Total Environment 2011, 409:4351-4360.
5. Besse J.-P., Kausch-Barreto C., Garric J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: application to the french situation and preliminary prioritization. Human and Ecological Risk Assessment: An International Journal 2008, 14:665-695.
6. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
7. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environmental Science & Technology 2006, 40:357-363.
8. Dirany A., Efremova Aaron S., Oturan N., Sires I., Oturan M.A., Aaron J.J. Study of the toxicity of sulfamethoxazole and its degradation products in water by a bioluminescence method during application of the electro-Fenton treatment. Analytical and Bioanalytical Chemistry 2011, 400:353-360.
9. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 2012, 86:665-671.
10. Gao P., Ding Y., Li H., Xagoraraki I. Occurrence of pharmaceuticals in a municipal wastewater treatment plant: mass balance and removal processes. Chemosphere 2012, 88:17-24.
11. Ghosh G.C., Okuda T., Yamashita N., Tanaka H. Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation. Water Science and Technology 2009, 59:779-786.
12. Gobel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environmental Science & Technology 2005, 39:3981-3989.
13. Gobel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. The Science of the Total Environment 2007, 372:361-371.
14. Golet E.M., Strehler A., Alder A.C., Giger W. Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Analytical Chemistry 2002, 74:5455-5462.
15. Golet E.M., Xifra I., Siegrist H., Alder A.C., Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environmental Science & Technology 2003, 37:3243-3249.
16. Gomez M.J., Martinez Bueno M.J., Lacorte S., Fernandez-Alba A.R., Aguera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66:993-1002.
17. Gracia-Lor E., Sancho J.V., Serrano R., Hernandez F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 2012, 87:453-462.
18. Gulkowska A., He Y., So M.K., Yeung L.W., Leung H.W., Giesy J.P., Lam P.K., Martin M., Richardson B.J. The occurrence of selected antibiotics in Hong Kong coastal waters. Marine Pollution Bulletin 2007, 54:1287-1293.
19. Gulkowska A., Leung H.W., So M.K., Taniyasu S., Yamashita N., Yeung L.W., Richardson B.J., Lei A.P., Giesy J.P., Lam P.K. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Research 2008, 42:395-403.
20. Huber M. Elimination of Pharmaceuticals during Oxidative Treatment of Drinking Water and Wastewater. Ph.D. Thesis 2004, Swiss Federal Institute of Technology, Zurich.
21. Jelic A., Gros M., Ginebreda A., Cespedes-Sanchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Research 2011, 45:1165-1176.
22. Jelic A., Fatone F., Di Fabio S., Petrovic M., Cecchi F., Barcelo D. Tracing pharmaceuticals in a municipal plant for integrated wastewater and organic solid waste treatment. The Science of the Total Environment 2012, 433:352-361.
23. Jia A., Wan Y., Xiao Y., Hu J. Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water Research 2012, 46:387-394.
24. Jones O.A., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Research 2002, 36:5013-5022.
25. Karthikeyan K.G., Meyer M.T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. The Science of the Total Environment 2006, 361:196-207.
26. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Illicit drugs and pharmaceuticals in the environment-forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities. Environmental Pollution 2009, 157:1773-1777.
27. Kosjek T., Andersen H.R., Kompare B., Ledin A., Heath E. Fate of carbamazepine during water treatment. Environmental Science & Technology 2009, 43:6256-6261.
28. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Science and Technology: A Journal of the International Association on Water Pollution Research 2004, 50:149-156.
29. Leung H.W., Minh T.B., Murphy M.B., Lam J.C., So M.K., Martin M., Lam P.K., Richardson B.J. Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environment International 2012, 42:1-9.
30. Li B., Zhang T. Mass flows and removal of antibiotics in two municipal wastewater treatment plants. Chemosphere 2011, 83:1284-1289.
31. Lienert J., Gudel K., Escher B.I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environmental Science & Technology 2007, 41:4471-4478.
32. Lindberg R.H., Wennberg P., Johansson M.I., Tysklind M., Andersson B.A. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environmental Science & Technology 2005, 39:3421-3429.
33. Martin J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. Journal of Hazardous Materials 2012, 239-240:40-47.
34. Martinez J.L. Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321:365-367.
35. MERCK, 2011. Manual MERCK. <> (accessed 08.12.11). http://www.merckmanuals.com/professional/index.html.
36. Miao X.S., Yang J.J., Metcalfe C.D. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environmental Science & Technology 2005, 39:7469-7475.
37. Nieto A., Borrull F., Pocurull E., Marcé R.M. Occurrence of pharmaceuticals and hormones in sewage sludge. Environmental Toxicology and Chemistry 2010, 29:1484-1489.
38. Oosterhuis M., Sacher F., Ter Laak T.L. Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. The Science of the Total Environment 2013, 442:380-388.
39. Ort C., Lawrence M.G., Reungoat J., Mueller J.F. Sampling for PPCPs in wastewater systems: comparison of different sampling modes and optimization strategies. Environmental Science & Technology 2010, 44:6289-6296.
40. Ortiz de Garcia S., Pinto Pinto G., Garcia Encina P., Irusta Mata R. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. The Science of the Total Environment 2013, 444:451-465.
41. Pomati F., Cotsapas C.J., Castiglioni S., Zuccato E., Calamari D. Gene expression profiles in zebrafish (Danio rerio) liver cells exposed to a mixture of pharmaceuticals at environmentally relevant concentrations. Chemosphere 2007, 70:65-73.
42. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Research 2009, 43:831-841.
43. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. The Science of the Total Environment 2006, 356:143-153.
44. Rowney N.C., Johnson A.C., Williams R.J. Cytotoxic drugs in drinking water: a prediction and risk assessment exercise for the Thames catchment in the United Kingdom. Environmental Toxicology and Chemistry/SETAC 2009, 28:2733-2743.
45. Ruhoy I.S., Daughton C.G. Beyond the medicine cabinet: an analysis of where and why medications accumulate. Environment International 2008, 34:1157-1169.
46. Samaras V.G., Stasinakis A.S., Mamais D., Thomaidis N.S., Lekkas T.D. Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. Journal of Hazardous Materials 2013, 244-245:259-267.
47. Scheurer M., Sacher F., Brauch H.J. Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany. Journal of Environmental Monitoring: JEM 2009, 11:1608-1613.
48. Sui Q., Huang J., Deng S., Yu G., Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Research 2010, 44:417-426.
49. Sui Q., Wang B., Zhao W., Huang J., Yu G., Deng S., Qiu Z., Lu S. Identification of priority pharmaceuticals in the water environment of China. Chemosphere 2012, 89:280-286.
50. ter Laak T.L., van der Aa M., Houtman C.J., Stoks P.G., van Wezel A.P. Relating environmental concentrations of pharmaceuticals to consumption: a mass balance approach for the river Rhine. Environment International 2010, 36:403-409.
51. Ternes T.A., Herrmann N., Bonerz M., Knacker T., Siegrist H., Joss A. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Research 2004, 38:4075-4084.
52. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Research 2005, 39:1289-1300.
53. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. The Science of the Total Environment 2012, 429:123-155.
54. Watkinson A.J., Murby E.J., Costanzo S.D. Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling. Water Research 2007, 41:4164-4176.
55. WebMD, 2011. <> (accessed 15.11.11). http://www.rxlist.com2011.
56. Xu W., Zhang G., Li X., Zou S., Li P., Hu Z., Li J. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Research 2007, 41:4526-4534.
57. Xue W., Wu C., Xiao K., Huang X., Zhou H., Tsuno H., Tanaka H. Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Research 2010, 44:5999-6010.
58. Yip C., Lee A.J. Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature. Clinical Therapeutics 2006, 28:1857-1866.
59. Yu Y., Wu L., Chang A.C. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. The Science of the Total Environment 2013, 442:310-316.
60. Zhang Y., Geissen S.U. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination. Chemosphere 2010, 80:1345-1352.
61. Zhou L.J., Ying G.G., Liu S., Zhao J.L., Yang B., Chen Z.F., Lai H.J. Occurrence and fate of eleven classes of antibiotics in two typical wastewater treatment plants in South China. The Science of the Total Environment 2013, 452-453:365-376.
62. Zorita S., Martensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. The Science of the Total Environment 2009, 407:2760-2770.